Category: Parkinson’s News

Join Sharp Coronado Hospital for an informational session on Living with Parkinson’s at the John D. Spreckels Center. The presentation will take place on Thursday, July 18, from 2-3 p.m. Learn about the latest research, treatment options, and strategies for managing symptoms of Parkinson’s. A Sharp Healthcare Specialist will lead this free one-hour session, offering […]

A new blood test could reveal Parkinson’s diagnoses up to seven years before symptoms emerge, researchers say. Experts discuss what the test means for the future of neurogenerative diseases.

”Off-the-shelf” wearables linked to a smartphone app could be useful in measuring disease progression, according to new research.

An interactive class is helping those effected by Parkinson’s disease by keeping them active with boxing.

University College London and University Medical Center Goettingen researchers developed an AI that can detect Parkinson’s disease.

The South Georgian Bay Parkinson’s Festival takes place June 22 at Bayview Park in Thornbury

There are signs in the blood.

A new study published in Nature Communications by researchers from UCL and University Medical Center Goettingen introduces a blood test using AI to pr

Sue Garland, 71, from York walked more than 100 miles after being diagnosed with Parkinson’s disease.

Preclinical models show benefit of afamelanotide as MC1R therapy in Parkinson’s DiseaseMELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) — CLINUVEL today announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease (PD or Parkinson’s) in fair-skinned patients. The program objectives are to determine whether afamelanotide – through melanocortin-1 receptor (MC1R) activation – is able to lower α-synuclein (a toxin) in blood levels in PD patients,